Inclusion Criteria:

- Male or female patients > 30 years and <=60 years of age.

- with a clinical diagnosis of primary liver cancer with PVTT, without any adjuvant
therapy.

- resectable tumors in the liver.

- PVTT type for II or III (based on the PVTT type system established by our groups),
confirmed through pre-operative imaging and pathologic examination.

- liver function grade A or B of the Child-Pugh classification.

- No dysfunction in major organs; Blood routine, kidney function, cardiac function and
lung function are basically normal. Hb ≥95g/L,WBC ≥3.000 cells/mm³,platelets ≥80.000
cells/mm³.

- Patients who can understand this trial and have signed information consent.

Exclusion Criteria:

- have had an allergic reaction following iodine or chemotherapeutic drugs.

- with extrahepatic metastasis.

- Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction,which may
affect the treatment of liver cancer.

- liver function:Child C.